Association between serum osteoprotegerin level and renal prognosis in nondialysis patients with chronic kidney disease in the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (the KNOW-CKD Study)

• Päätekijät: Tae Ryom Oh (Tekijä), Chana Myeong (Tekijä), Su Hyun Song (Tekijä), Hong Sang Choi (Tekijä), Sang Heon Suh (Tekijä), Chang Seong Kim (Tekijä), Eun Hui Bae (Tekijä), Wookyung Chung (Tekijä), Kyu Hun Choi (Tekijä), Kook Hwan Oh (Tekijä), Seong Kwon Ma (Tekijä), Soo Wan Kim (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: The Korean Society of Nephrology, 2022-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background Osteoprotegerin is an important regulator of bone metabolism and vascular calcification. The association between serum osteoprotegerin level and chronic kidney disease (CKD) progression has not been elucidated. We investigated the prognostic value of serum osteoprotegerin levels in nondia...